Action

T790M; EGFR

Alt Name

Approval Jurisdiction

2020 China

Approved for clinical use

Advanced mutation +ve NSCLC

Brutto

CAS

1899921-05-1

Commercial Vendor

Hansoh Pharma

Compound Image

Almonertinib.png

Compound name

Almonertinib

InChI

InChI=1S/C30H35N7O2/c1-6-29(38)32-24-17-25(28(39-5)18-27(24)36(4)16-15-35(2)3)34-30-31-14-13-23(33-30)22-19-37(20-11-12-20)26-10-8-7-9-21(22)26/h6-10,13-14,17-20H,1,11-12,15-16H2,2-5H3,(H,32,38)(H,31,33,34)

InChI Key

DOEOECWDNSEFDN-UHFFFAOYSA-N

MW

525.60

PubChem CID

121280087

Reference

Reference 2

SMILES

CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC

Approved Drug List

1